We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.56%
2 Industrials 11.54%
3 Communication Services 11.47%
4 Financials 11.2%
5 Technology 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
301
Pliant Therapeutics
PLRX
$65M
– –
-490,000
Closed -$14.3M
RCKT icon
302
Rocket Pharmaceuticals
RCKT
$392M
– –
-350,000
Closed -$15.5M
SMRT icon
303
SmartRent
SMRT
$276M
– –
-400,000
Closed -$4.92M
TBPH icon
304
Theravance Biopharma
TBPH
$878M
– –
-96,000
Closed -$1.39M
TGTX icon
305
TG Therapeutics
TGTX
$7.42B
– –
-500,000
Closed -$19.4M
IMGN
306
DELISTED
Immunogen Inc
IMGN
– –
-750,000
Closed -$4.94M
EMBKW
307
DELISTED
Embark Technology, Inc. Warrants
EMBKW
– –
-92,675
Closed -$154K
FNCH
308
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
– –
-6,178
Closed -$2.61M
PSPC.U
309
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
– –
-800,000
Closed -$8.31M
ALBO
310
DELISTED
Albireo Pharma Inc
ALBO
– –
-250,000
Closed -$8.79M
CPARU
311
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
– –
-753,900
Closed -$7.57M
SHQAU
312
DELISTED
Shelter Acquisition Corporation I Units
SHQAU
– –
-1,650,000
Closed -$16.5M
TPTX
313
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-465,000
Closed -$36.3M
SPAQ.WS
314
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
– –
-15,013
Closed -$18K
CVA
315
DELISTED
Covanta Holding Corporation
CVA
– –
-115,000
Closed -$2.02M
MDLA
316
DELISTED
Medallia, Inc.
MDLA
– –
-240,000
Closed -$8.1M
SRNGW
317
DELISTED
Soaring Eagle Acquisition Corp. Warrant
SRNGW
– –
-100,000
Closed -$330K
SRNG
318
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
– –
-500,000
Closed -$4.98M
PFPT
319
DELISTED
Proofpoint, Inc.
PFPT
– –
-304,500
Closed -$52.9M
CEREW
320
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
– –
-134,175
Closed -$1.91M
MXIM
321
DELISTED
Maxim Integrated Products
MXIM
– –
-4,515,000
Closed -$476M
TLND
322
DELISTED
Talend S.A. American Depositary Shares
TLND
– –
-380,000
Closed -$24.9M
ALXN
323
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-7,707,500
Closed -$1.42B
WORK
324
DELISTED
Slack Technologies, Inc.
WORK
– –
-10,437,300
Closed -$462M
INBX
325
DELISTED
Inhibrx, Inc. Common Stock
INBX
– –
-569,328
Closed -$15.7M
9 10 11 12
13

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Farallon Capital Management held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Farallon Capital Management withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Farallon Capital Management opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Farallon Capital Management's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Farallon Capital Management added most to Aramark in Q3 2021, an estimated $209M increase.
  • Farallon Capital Management's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Farallon Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Farallon Capital Management's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Farallon Capital Management opened 40 new positions and closed 34 in Q3 2021.
  • Farallon Capital Management's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.